← Leaderboards
Nisha J D'silva
University Of Michigan At Ann Arbor
$14,161,982
Attributed
$16,057,941
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,057,941 · 11
By mechanism
R35$8,056,086 · 1
R01$5,914,080 · 3
R21$845,000 · 2
K23$609,833 · 1
K02$472,270 · 1
R03$150,672 · 1
Top collaborators
- Laura Rozek5 shared
- Maureen Agnes Sartor5 shared
- Moran Amit1 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- John O.l. Delancey$16,589,032
- Gregory T Wolf$6,682,960
- Quintin Pan$6,742,395
- Dean E. Brenner$31,108,993
- Amid I. Ismail$4,909,161
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMolecularHead And Neck CancerTumor ProgressionBaseMalignant NeoplasmsCellsSiteNeoplasm MetastasisRecurrenceNovel StrategiesMalignant Mouth NeoplasmEpithelial To Mesenchymal TransitionLinkCancer CellPrognosticMediatingIn VivoHead And Neck Squamous Cell CarcinomaIn VitroEventFigs - DietaryResistance DevelopmentDiagnosis
Grant awards (40)
Cancer Neuroscience: Crossing Disciplines to Revolutionize Cancer Treatment$10,000
R13 · FY2025 · CA
Improving Survival in Oral Cancer by Disruption of Tumor Progression$993,500
R35 · FY2024 · DE · contact PI
Downstream effects of HPV integration on survival/metastasis in oropharyngeal cancer$517,177
R01 · FY2024 · CA
Improving Survival in Oral Cancer by Disruption of Tumor Progression$1,013,830
R35 · FY2023 · DE · contact PI
Downstream effects of HPV integration on survival/metastasis in oropharyngeal cancer$575,080
R01 · FY2023 · CA
Improving Survival in Oral Cancer by Disruption of Tumor Progression$1,001,292
R35 · FY2022 · DE · contact PI
Downstream effects of HPV integration on survival/metastasis in oropharyngeal cancer$584,593
R01 · FY2022 · CA
Improving Survival in Oral Cancer by Disruption of Tumor Progression$1,013,126
R35 · FY2021 · DE · contact PI
Downstream effects of HPV integration on survival/metastasis in oropharyngeal cancer$584,072
R01 · FY2021 · CA
Improving Survival in Oral Cancer by Disruption of Tumor Progression$1,009,712
R35 · FY2020 · DE · contact PI
Downstream effects of HPV integration on survival/metastasis in oropharyngeal cancer$575,516
R01 · FY2020 · CA
Improving Survival in Oral Cancer by Disruption of Tumor Progression$1,007,799
R35 · FY2019 · DE · contact PI
Improving Survival in Oral Cancer by Disruption of Tumor Progression$1,009,811
R35 · FY2018 · DE · contact PI
Improving Survival in Oral Cancer by Disruption of Tumor Progression$1,007,016
R35 · FY2017 · DE · contact PI
Role of EZH2 in Invasion and Migration in the Oral Mucosa$349,875
R01 · FY2016 · DE · contact PI
Role of EZH2 in Invasion and Migration in the Oral Mucosa$349,875
R01 · FY2015 · DE · contact PI
Impact of nerves on cancer initiating cells and tumor progression$193,750
R21 · FY2015 · DE · contact PI
Role of EZH2 in Invasion and Migration in the Oral Mucosa$349,875
R01 · FY2014 · DE · contact PI
Impact of nerves on cancer initiating cells and tumor progression$233,250
R21 · FY2014 · DE · contact PI
Role of EZH2 in Invasion and Migration in the Oral Mucosa$349,875
R01 · FY2013 · DE · contact PI
Biomarkers in Head and Neck Cancer Progression$94,454
K02 · FY2013 · DE · contact PI
Biomarkers in Head and Neck Cancer Progression$94,454
K02 · FY2012 · DE · contact PI
Role of Rap1 in cadherin and integrin mediated cross-talk in oral keratinocytes$324,810
R01 · FY2011 · DE · contact PI
Biomarkers in Head and Neck Cancer Progression$94,454
K02 · FY2011 · DE · contact PI
Role of Rap1 in cadherin and integrin mediated cross-talk in oral keratinocytes$334,856
R01 · FY2010 · DE · contact PI
Biomarkers in Head and Neck Cancer Progression$94,454
K02 · FY2010 · DE · contact PI
Role of Rap1 in cadherin and integrin mediated cross-talk in oral keratinocytes$338,238
R01 · FY2009 · DE · contact PI
Characterization of the Immunomic Profile of Head and Neck Cancer$190,000
R21 · FY2009 · DE · contact PI
Biomarkers in Head and Neck Cancer Progression$94,454
K02 · FY2009 · DE · contact PI
Role of Rap1 in cadherin and integrin mediated cross-talk in oral keratinocytes$338,238
R01 · FY2008 · DE · contact PI
Characterization of the Immunomic Profile of Head and Neck Cancer$228,000
R21 · FY2008 · DE · contact PI
Role of Rap1 in cadherin and integrin mediated cross-talk in oral keratinocytes$342,000
R01 · FY2007 · DE · contact PI
Rap 1-Mediated Protein Transport in Oral Cancer$74,214
R03 · FY2006 · DE · contact PI
Rap 1-Mediated Protein Transport in Oral Cancer$76,458
R03 · FY2005 · DE
RAP1A AND RAP1B IN THE DIAGNOSIS AND TMT - ORAL CANCER$130,680
K23 · FY2004 · DE
RAP1A AND RAP1B IN THE DIAGNOSIS AND TMT - ORAL CANCER$130,545
K23 · FY2003 · DE
RAP1A AND RAP1B IN THE DIAGNOSIS AND TMT - ORAL CANCER$119,217
K23 · FY2002 · DE
CORE--TISSUE FACILITY$0
P50 · FY2002 · CA
RAP1A AND RAP1B IN THE DIAGNOSIS AND TMT - ORAL CANCER$115,999
K23 · FY2001 · DE
RAP1A AND RAP1B IN THE DIAGNOSIS AND TMT - ORAL CANCER$113,392
K23 · FY2000 · DE